tiprankstipranks
Climb Bio (CLYM)
NASDAQ:CLYM
US Market
Want to see CLYM full AI Analyst Report?

Compare Climb Bio (CLYM) vs. Competitors

700 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Climb Bio
$9.16
$651.05M
-8.51
834.45%
13 Buy
0 Hold
0 Sell
Strong Buy
Agenus
$4.79
$146.68M
12.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
TuHURA Biosciences
$2.92
$151.56M
-1.21
-39.85%
3 Buy
0 Hold
0 Sell
Strong Buy
Ovid Therapeutics
$2.91
$484.50M
3.44
862.07%
8 Buy
0 Hold
0 Sell
Strong Buy
Cognition Therapeutics
$1.19
$108.12M
-3.71
292.03%
2 Buy
0 Hold
0 Sell
Moderate Buy
Tevogen Bio Holdings
$0.32
$31.32M
-2.94
-87.16%
0 Buy
1 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CLYM
Climb Bio
11.12
9.85
775.59%
AGEN
Agenus
3.26
-0.12
-3.55%
HURA
TuHURA Biosciences
2.40
-1.70
-41.46%
OVID
Ovid Therapeutics
2.79
2.50
875.52%
CGTX
Cognition Therapeutics
1.18
0.86
268.75%
TVGN
Tevogen Bio Holdings
7.00
-51.00
-87.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts